Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbadc41aa91592752369d88100f96411 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-303 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
1999-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3db3e4520da9f17e00d02e38fc5d1fa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7f3d6f844f6f06e6936d3b3f095f79c |
publicationDate |
2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2000026312-A |
titleOfInvention |
Tumor treatment |
abstract |
Bronchial tissue and thyroid for administering antibodies in fractional doses that provide sustained high plasma levels of the antibodies throughout the course of therapy and provide enhanced access of the antibodies to the tumor site To provide a medicament for treating tumors derived from various glandular structures including mammary gland, sweat gland and exocrine and endocrine pancreas. An agent for treating a tumor derived from bronchial tissue or glandular structure tissue, comprising a monoclonal antibody that specifically binds to an epitope of the 17-1A antigen, and suitable for multiple parenteral administrations. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016087334-A |
priorityDate |
1986-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |